Myriad Genetics
MYGN
MYGN
233 hedge funds and large institutions have $1.61B invested in Myriad Genetics in 2017 Q1 according to their latest regulatory filings, with 46 funds opening new positions, 96 increasing their positions, 57 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
233
Holders Change
+10
Holders Change %
+4.48%
% of All Funds
5.81%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
46
Increased
96
Reduced
57
Closed
29
Calls
$3.62M
Puts
$8.89M
Net Calls
-$5.27M
Net Calls Change
+$11.2M
Top Buyers
| 1 |
1
BlackRock
New York
|
$183M |
| 2 |
2
D.E. Shaw & Co
New York
|
$80.6M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$50.7M |
| 4 |
4
Vanguard Group
Malvern,
Pennsylvania
|
$120M |
| 5 |
CCM
5
Consonance Capital Management
New York
|
$57.1M |
